The Metagenomics Market size was estimated USD 1.8 billion in 2022 and is expected to reach USD 5.9 billion by 2030 at a CAGR of 16.2% during the forecast period of 2023-2030.    

The Metagenomics Market is a rapidly growing sector in the field of genomics research and analysis. Metagenomics refers to the study of genetic material recovered directly from environmental samples, such as soil, water, or even human gut microbiome. This approach allows scientists to explore the vast diversity of microorganisms present in these samples and understand their functional roles in various ecosystems.

One of the key drivers behind the growth of the metagenomics market is the increasing awareness about the importance of studying microbial communities for human health and environmental sustainability. The human microbiome, for instance, has been linked to numerous diseases and conditions, including obesity, autoimmune disorders, and mental health issues. As a result, there is a growing demand for metagenomic analysis tools and services that can provide insights into these complex microbial communities.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/3719

Technological advancements have also played a significant role in propelling the metagenomics market forward. Next-generation sequencing (NGS) technologies have revolutionized DNA sequencing by enabling high-throughput analysis at These advancements have allowed researchers to study the composition and function of the microbiome in greater detail, leading to a better understanding of its role in human health and disease.

Furthermore, the integration of bioinformatics tools and machine learning algorithms has further accelerated the progress of metagenomics research. These computational approaches have enabled the analysis of vast amounts of sequencing data, facilitating the identification of novel microbial species and the characterization of their genetic potential. By harnessing the power of big data analytics, scientists can now uncover intricate relationships between the microbiome and various diseases, paving the way for the development of targeted therapies and personalized medicine. Additionally, the continuous advancements in metagenomics techniques have opened up new avenues for exploring environmental microbiomes, offering insights into the ecological impact of microorganisms and their potential applications in bioremediation and sustainable agriculture. As technology continues to evolve, the metagenomics field holds immense promise for unraveling the complexities of microbial communities and their impact on human and environmental health.

KEY MARKET SEGMENTS

By Product

·         Kits & Reagents

·         Sequencing & Data Analytics Services

·         Software

In 2022, kits & reagents segment is expected to held the highest market share of 61.4% during the forecast period. During the experimental preparation of the sample, a number of reagents are used in sequencing. The market is dominated by established businesses such as F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., and Illumina Inc., which offer a diverse range of reagents to meet the needs of sequencing.

 By Workflow

·         Pre-sequencing

·         Sequencing

·         Data Analysis

In 2022, Sequencing segment is expected to dominate the market share of 53.8% during the forecast period. This can be attributed to the technological advancements in sequencing, which have made it more cost-effective and accurate. Companies routinely use sequencing methods for genetic research, which is an important component of genetic testing. Technology advancements have decreased the cost of sequencing by 28.2% yearly.

By Technology

·         Shotgun Sequencing

·         16S Sequencing

·         Whole Genome Sequencing

·         Others

In 2022, Shotgun Sequencing segment is expected to dominate the market share of 16.2% during the forecast period. Many academic institutions and research centers are incorporating technology into their genetic research. For example, in July 2022, a paper published on the Arthritis & Rheumatology portal claimed that the genetic background, as well as disease activity, influences the makeup of gut microbiota. To reach such result, the team used shotgun sequencing.

By Application

·         Environmental

·         Clinical Diagnostics

·         Drug Discovery

·         Biotechnology

·         Food & Nutrition

·         Others

Major Players Listed in the Report are as Follows:

Bio-Rad Laboratories, Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd., and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)